TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,404 results
Show filters and sorting

AI gains · 779

68
GainHealth· Stable· Evidence: Moderate (1 source)

A survival-oriented machine learning framework distilled epigenomic and transcriptomic data into a 25-gene lipid-metabolic signature that stratified bladder cancer patients by risk across multiple cohorts and identified FASN and SCD as inhibitable drivers of proliferation and migration in cell models.

On July 24, 2026, a peer-reviewed study reported integration of promoter methylation and RNA sequencing data from bladder cancer tumors and adjacent normal tissue to identify epigenetically regulated genes, then used a survival-oriented machine learning framework to distill a 25-gene signature enriched for cell cycle and lipid metabolism. The signature stratified patients into high- and low-risk groups in the discovery set and 4 independent validation cohorts, and network analysis highlighted fatty acid synthase and stearoyl-coenzyme A desaturase whose inhibition reduced proliferation and migration in cell line assays.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 26, 2026 · TRV-2026-0569

68
GainHealth· Stable· Evidence: Moderate (1 source)

Persona-driven document-level augmentation with multiple LLM personas increased BioBERT disease NER F1 over gold-standard-only training on both RareDis and NCBI disease datasets.

Researchers tested whether large language model rephrasing controlled by persona prompts and XML tags could expand scarce expert-annotated data for disease named entity recognition. They applied the method to RareDis, a low-resource rare disease corpus, and NCBI disease, a general disease benchmark, and compared BioBERT performance with and without augmented variants.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 25, 2026 · TRV-2026-0562

68
GainHealth· Stable· Evidence: Moderate (1 source)

A ridge regression-based 26-gene programmed cell death riskscore built from single-cell and nine bulk cohorts stratified breast cancer patients by risk and predicted overall survival, and PDIA4 knockdown reduced tumor growth.

By the publication date of July 25, 2026, researchers had integrated single-cell RNA sequencing of breast tumors with nine bulk cohorts to study 19 programmed cell death modalities, applying 14 machine learning algorithms to build a 26-gene prognostic signature. The ridge regression-based PCD riskscore was integrated into a clinical nomogram and validated experimentally, including PDIA4 overexpression in 50 paired tissues and functional inhibition studies.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 25, 2026 · TRV-2026-0561

68
GainScience· Stable· Evidence: Moderate (1 source)

EMFF-2025 provides DFT-level accuracy for structure, mechanical properties, and decomposition across 20 C, H, N, O energetic materials while enabling faster iteration than first-principles methods.

On 2025-11-17, researchers described EMFF-2025, a general neural network potential for C, H, N, and O-based high-energy materials. Built with transfer learning from minimal DFT calculations, the model was evaluated on 20 HEMs for structure, mechanical properties, and decomposition, and combined with PCA and correlation heatmaps to track structural evolution across temperatures.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0555

AI problems · 625

67
ProblemOther· Stable· Evidence: Moderate (1 source)

Users completing innovation tasks with AIGC may experience alienation outcomes including cognitive fixation, degradation risk, and problem risk.

As of the July 10 2026 publication date, researchers reported a grounded theory study of 1,502 public articles and more than 120,000 words of interviews to examine how AIGC influences user innovation. They built a TCEU framework where technical factors and content factors act as external drivers and user factors act as internal drivers, with technology popularity and platform convenience as moderators.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0112

67
ProblemPolicy· Stable· Evidence: Moderate (1 source)

VGenAI content did not provide resource-constrained minor parties with competitive engagement benefits, leaving engagement asymmetries between major and minor parties intact.

During the four weeks before the 2025 German federal election, 37 parties' Facebook and Instagram accounts published nearly 1,000 VGenAI images and videos. Minor parties used VGenAI at higher rates than major parties, consistent with lower-cost access to professional visuals, while mainstream major parties disclosed AI origins more frequently than minor parties and the AfD, which used more photorealistic, citizen, criminal, and negative-tone imagery.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0109

67
ProblemHealth· Stable· Evidence: Moderate (1 source)

By 2027-01-01, recent suicides and other serious harms were allegedly linked to companion AI chatbot use.

As of the 2027-01-01 publication date, companion AI chatbots were described as increasingly used to provide friendship, emotional support, and quasi-romantic relationships. The article notes reported benefits for loneliness and mental health, alongside recent suicides and other serious harms allegedly linked to such systems, and states it interrogates gaps in existing ethical and legal frameworks through four lenses including anthropomorphism.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%88

Updated Jul 12, 2026 · TRV-2026-0054

Recomputed live from the record · Sep 15, 2026, 6:11 AM